Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
Clinical trial NCT03887026 · COMPLETED
Trial details
- NCT number
- NCT03887026
- Sponsor
- Emergo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2019-05-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.